Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$197.55
1.180.60%
At Close: -
$197.55
00.00%
After Hours: Aug 23, 4:37 PM EDT
15 minutes delayed
Comments
Loading...
Overview Rating
Speculative
AbbVie (NYSE:ABBV) Stock Quotes, Forecast and News Summary
AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.
| Open | $197.25 |
| Close | $197.55 |
| Volume / Avg. | 4.72M / 5.47M |
| Day Range | $196.23 - $197.98 |
| 52 Wk Range | 135.85 - 197.54 |
| Market Cap | $348.85B |
| P/E Ratio | 65.68 |
| Dividend Yield | 3.16% |
| Exchange | NYSE |
| RSI | 73 |
| Short Interest | 0.99% |
| Days to Cover | 3.07 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Abbvie Inc
Sector
Health Care
Industry
Biotechnology
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy AbbVie (ABBV) stock?
You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.
Who are AbbVie (ABBV) competitors?
Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for AbbVie (ABBV) stock?
AbbVie has a consensus price target of $176.56.
What is the current price for AbbVie (ABBV)?
The stock price for AbbVie (NYSE: ABBV) is $197.55 last updated August 23, 2024 at 4:37 PM EDT.
Does AbbVie (ABBV) pay a dividend?
A quarterly cash dividend of 1.55 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2024 to stockholders of record on July 15, 2024.
When is AbbVie (NYSE:ABBV) reporting earnings?
AbbVie’s Q3 earnings are confirmed for Friday, October 25, 2024.
Is AbbVie (ABBV) going to split?
There is no upcoming split for AbbVie.
What sector and industry does AbbVie (ABBV) operate in?
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.